Evommune revenue was N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EVMN annual revenue was $13.0M, with 85.7% growth year-over-year.
EVMN revenue history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
Be the first to know when EVMN announces revenue.
EVMN Revenue History By Year
EVMN Yearly Revenue
EVMN Revenue
EVMN Change
EVMN Revenue Growth
2025-12-31
$13.00M
$6.00M
+85.71%
2024-12-31
$7.00M
$2.00M
+40.00%
2023-12-31
$5.00M
N/A
N/A
1 of 1
Evommune Revenue FAQ
What was EVMN's revenue last quarter?
Evommune (NYSE: EVMN) reported Q1 2026 revenue of $0.00 up 100% year over year. In the same quarter last year, Evommune's revenue was $3.00 million.
What was Evommune's revenue in 2025?
Evommune's annual revenue for the twelve months ending Dec 31, 2025 was $13.00 million, a 85.71% increase year over year.
How much does Evommune make in a day?
Based on Evommune annual revenue for the past two years, EVMN makes an average of $27,397.26 per day.
What was Evommune's annual revenue growth in the past year?
As of Q2 2026, Evommune's revenue has grown null year over year. Evommune's revenue in the past year totaled N/A.
How much does Evommune make in a year?
Evommune's revenue by year for the past two years is:
Evommune's revenue for the twelve months ending Dec 31, 2025 was $13.00 million, a 85.71% increase year over year.
Evommune's annual revenue for Dec 31, 2024 was $7.00 million, a 40% increase from 2023.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.